by Vandana Singh | Feb 9, 2026 | General
Roche Holdings AG (OTC:RHHBY) on Monday shared new late-breaking data from the Phase 3 FENtrepid study of the investigational Bruton’s tyrosine kinase (BTK) inhibitor fenebrutinib. Fenebrutinib is an investigational, oral, highly selective, reversible...
by Rishabh Mishra | Feb 9, 2026 | General
While headlines frequently cite artificial intelligence (AI) as the catalyst for recent workforce reductions, economist Justin Wolfers argues that the data tells a different story: one of infrastructure investment rather than human displacement. The AI Layoff Myth...
by Vandana Singh | Feb 9, 2026 | General
Johnson & Johnson (NYSE:JNJ) on Friday after hours released data from the OMNY-AF pilot study, a prospective, single-arm, multi-center trial. The study pairs the OMNYPULSE Catheter, a 12 mm large-tip focal catheter featuring contact-force sensing and bipolar,...
by Akanksha Bakshi | Feb 9, 2026 | General
On Monday, Uber Technologies Inc. (NYSE:UBER) announced a strategic agreement to acquire Getir’s delivery portfolio in Türkiye, which includes food, grocery, retail, and water delivery services. This move demonstrates Uber’s commitment to expanding its presence in the...
by Avi Kapoor | Feb 9, 2026 | General
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst...
Recent Comments